Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
4.220
+0.090 (2.18%)
At close: Nov 17, 2026, 4:00 PM EST
4.080
-0.140 (-3.32%)
After-hours: Nov 17, 2026, 5:08 PM EST

Passage Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
20.0319.8824.9941.5845.5460.06
Research & Development
14.3523.2840.1861.4283.75117.67
Operating Expenses
34.3843.1565.17103129.29177.73
Operating Income
-34.38-43.15-65.17-103-129.29-177.73
Interest & Investment Income
2.32.34.35.62.33.12
Other Non Operating Income (Expenses)
-0.071.471.330.73-0.03-
EBT Excluding Unusual Items
-32.15-39.38-59.53-96.67-127.03-174.61
Merger & Restructuring Charges
-----6.1-
Gain (Loss) on Sale of Investments
------2.78
Asset Writedown
-3.51-6.15-5.23-5.39--
Pretax Income
-33.08-45.52-64.77-102.06-136.13-185.39
Net Income
-33.08-45.52-64.77-102.06-136.13-185.39
Net Income to Common
-33.08-45.52-64.77-102.06-136.13-185.39
Net Income Growth
------
Shares Outstanding (Basic)
333333
Shares Outstanding (Diluted)
333333
Shares Change
1.18%3.06%12.48%0.58%2.03%38.14%
EPS (Basic)
-10.33-14.35-21.04-37.29-50.02-69.51
EPS (Diluted)
-10.33-14.35-21.04-37.29-50.02-69.51
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-32.65-31.51-47.99-78.41-120.48-144.52
Free Cash Flow Per Share
-10.19-9.93-15.59-28.65-44.27-54.19
EBITDA
-34.05-42.42-62.09-99.28-125.62-176.19
D&A For EBITDA
0.330.733.083.723.681.54
EBIT
-34.38-43.15-65.17-103-129.29-177.73
SEC Filings: 10-K · 10-Q